Skip to main content
Log in

The Evaluation of Argyrophilic Nucleolar Organizing Region Proteins in Fine-Needle Aspiration Samples of Thyroid

  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

Argyrophilic nucleolar organizing region associated proteins (AgNORs) have been shown to be of interest in a variety of different diseases including thyroid disorders. Our aim was to distinguish benign thyroid lesions from papillary thyroid carcinoma (PTC) via AgNOR count and with a new approach, via AgNOR surface area/total nuclear surface area (NORa/TNa) proportions in the nuclei on fine-needle aspiration (FNA) materials. Thirty patients (eight men and 22 women) whose FNA was compatible with benign lesion and 26 patients (eight men and 18 women) whose FNA was compatible with PTC were included in the study. Fine-needle aspiration materials were stained for AgNOR detection according to a specific protocol. One hundred nuclei per individual have been evaluated, and AgNOR number and NORa/TNa proportions of individual cells were measured and calculated by using a computer program. Patients with PTC had significantly (p < 0.001) higher AgNOR count (4.6 ± 1.2%) than in the patients with benign lesions (2.0 ± 0.5%). Additionally, patients with PTC had significantly (p < 0.001) higher NORa/TNa (13.4 ± 2.4) than in the patients with benign lesion (5.7 ± 1.0). Modified method of AgNOR staining is an easy and reliable method for evaluating proliferation activity of cells in malignant and benign thyroid lesions and it may contribute to routine cytopathology in inconclusive situations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Hernandez-Verdun D & Louvet E. The nucleolus: structure, functions and associated diseases. Medical Sciences 20:3744, 2004.

    Google Scholar 

  2. Trere D. AgNOR staining and quantification. Micron 31:127–131, 2000.

    Article  PubMed  CAS  Google Scholar 

  3. Imamoglu N, Demirtas H, Donmez-Altuntas H, et al. Higher NORs–expression in lymphocyte of trisomy 21 babies/children: in vivo evaluation. Micron 36:503–507, 2005.

    Article  PubMed  CAS  Google Scholar 

  4. Nairn ER, Crocker J & Mcgovern J. Limited value of AgNOR enumeration in assesment of thyroid neoplasms. Journal of Clinical Pathology 41:1136, 1988.

    Article  PubMed  CAS  Google Scholar 

  5. Crocker J & Nar P. Nucleolar organizer regions in lymphomas. Journal of Pathology 151:111–118, 1987.

    Article  PubMed  CAS  Google Scholar 

  6. Abboud P, Lorenzato M, Joly D, et al. Prognostic value of a proliferation index including MIB1 and argyrophilic nucleolar organizer regions proteins in node-negative breast cancer. American Journal of Obstetrics and Gynecology 199:146–150, 2008.

    Article  PubMed  CAS  Google Scholar 

  7. Derenzini M, Ceccarelli C, Santini D, et al. The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 status. Journal of Clinical Pathology 55:755–761, 2004.

    Article  Google Scholar 

  8. Cardillo MR. AgNOR counts are useful in cervical smears. Diagnostic Cytopatholgy 8:208–210, 1992.

    Article  CAS  Google Scholar 

  9. Howat AJ, Giri DD, Cotton DW, et al. Nucleolar organizer regions in Spitz nevi and malignant melanomas. Cancer 63:474–478, 1989.

    Article  PubMed  CAS  Google Scholar 

  10. Cibas ES, & Ali SZ. NCI Thyroid FNA State of the Science Conference. The Bethesda System For Reporting Thyroid Cytopathology. American Journal of Clinical Pathology 132:658–665. 2009.

    Article  PubMed  Google Scholar 

  11. Benn PA & Perle M. Chromosome staining and banding techniques. In: Rooney D.E. Czepulkowski BH. (eds). Human Cytogenetics, Constitutional Analysis, actical approach, Vol 1. Oxford Univ. Press 91–118, 1986

  12. Lindner LE. Improvements in the silver-staining technique for nucleolar organizer regions (AgNOR). Journal of Histochemistry and Cytochemistry 41:439–445, 1993.

    Article  PubMed  CAS  Google Scholar 

  13. Demirtas H, Imamoglu N, Donmez H, et al. Condensed chromatin surface and NOR surface enhancement in mitogen-stimulated lymphocytes of Down syndrome patients. Ann Genet-Paris 44:77–82, 2001.

    PubMed  CAS  Google Scholar 

  14. Pich A, Chiusa L, Navone R. Prognostic relevance of cell proliferation in head and neck tumours. Annals of Oncology 15:1319–1329, 2004.

    Article  PubMed  CAS  Google Scholar 

  15. Jones AS. Prognosis in mouth cancer: tumour factors. European Journal of Cancer Part B Oral Oncolog 30:8–15, 1994.

    Article  Google Scholar 

  16. Underwood JC. AgNOR measurements as indices of proliferation, ploidy and prognosis. Clinical Molecular Pathology 48:M239-M240, 1995.

    Article  PubMed  CAS  Google Scholar 

  17. Bukhari MH, Niazi S, Hashmi I, et al. Use of AgNOR index in grading and differential diagnosis of astrocytic lesions of brain. Pakistan Journal of Medical Sciences 23:206–210, 2007.

    Google Scholar 

  18. Camargo R.S., Shirata N.K., di Loreto C, et al. Significance of AgNOR measurement in thyroid lesions. Analysis and Quantitative Cytology and Histology 28:188–192, 2006.

    Google Scholar 

  19. Slowinska-Klencka D, Klencki M, Popowicz B, et al. AgNOR quantification in the diagnosis of follicular pattern thyroid lesions. Analysis and Quantitaive Cytology and Histology 25:347–352, 2003.

    Google Scholar 

  20. Slowi’nska-Klencka D, Klencki M, Popowicz B, et al. Multiparameter analysis of AgNOR in thyroid lesions: comparison with PCNA expression. Histol Histopathol 19:785–792, 2004.

    Google Scholar 

  21. Augustynowicz A, Dzieciol J, Dadan J, et al. Proliferative activity of the thyroid oxyphilic tumor cells estimated by means of quantitative analysis of silver stained nucleolar organizer regions (AgNORs). Folia Histochemica et Cytobiologica 39:(Suppl 2) 203–204, 2001.

    PubMed  Google Scholar 

  22. Dernburg AF & Misteli T. Nuclear architecture an island no more. Devolepmental Cell 12:329–34, 2007.

    Article  CAS  Google Scholar 

  23. Misteli T. Concepts in nuclear architecture. Bioessays 27:477–487, 2005.

    Article  PubMed  CAS  Google Scholar 

  24. Zink D, Fischer AH & Nickerson JA. Nuclear structure in cancer cells. Nature Reviews Cancer 4:677–687, 2004.

    Article  PubMed  CAS  Google Scholar 

  25. Zaidi SK, Young DW, Javed A, et al. Nuclear microenvironments in biological control and cancer. Nature Reviews Cancer 7:454–463, 2007.

    Article  PubMed  CAS  Google Scholar 

  26. Gilbert DM & Zink D. Intranuclear changes in cancer cells. Genome Biology 8:312, 2007.

    Article  PubMed  Google Scholar 

  27. Derenzini M, Pasquinelli G, O’Donohue MF, et al. Structural and functional organization of ribosomal genes within the mammalian cell nucleolus. Journal of Histochemistry and Cytochemistry 54:131–145, 2006.

    Article  PubMed  CAS  Google Scholar 

  28. Eroz R, Cucer N, Unluhizarci K, et al. Evaluation of AgNOR spot number in thyroid papillary carcinoma and normal cells nuclei. Journal of Health Sciences 19 (2):102–107, 2010.

    Google Scholar 

Download references

Funding

The Medical Research Council of Erciyes University (ERUBAP, Project No. B-538) supported this work.

Declaration of interest

There is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Recep Eroz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eroz, R., Cucer, N., Karaca, Z. et al. The Evaluation of Argyrophilic Nucleolar Organizing Region Proteins in Fine-Needle Aspiration Samples of Thyroid. Endocr Pathol 22, 74–78 (2011). https://doi.org/10.1007/s12022-011-9161-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12022-011-9161-z

Keywords

Navigation